Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no study data or page content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedGlossary visibility controls were added (Show glossary / Hide glossary). QC labeling and revision notes were updated in Study Record Dates: capitalization adjusted for 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' updated to 'No FEAR Act data', and a new 'Revision: v3.4.0' entry replacing the previous version.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no visible changes to the study details page.SummaryDifference0.0%

- Check63 days agoChange DetectedExpanded the Locations section to list each state individually (California, Colorado, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington) and added Revision: v3.3.3, replacing the previous aggregated state listings (v3.3.2).SummaryDifference2%

- Check92 days agoChange DetectedThe changes modify publication metadata by adding statements that publications are provided voluntarily and automatically filled from PubMed, and by updating the revision label to v3.3.2, while removing the prior wording about PubMed-derived publications and the v3.2.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.